GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Compound class:
Peptide
Comment: GAL-101 (Galimedix Therapeutics) is a small bioactive peptide that reduces formation of neurotoxic amyloid β 1-42 (Aβ1-42) oligomers [1-3]. GAL-101 binds to aromatic residues in Aβ1-42 recognition interfaces during oligomer assembly and also breaks the protein's β strands [1]. This mechanism is proposed to reduce neuronal damage in Aβ-driven diseases.
|
|
Selectivity at ligand targets | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|